Michael Vi/iStock Editorial via Getty Images
AbbVie (NYSE:ABBV) shares snap seven straight sessions of losses, as the stock ended 0.71% higher at $202.72 on Thursday.
The biopharmaceutical company lost nearly 6% in the preceding seven sessions. The stock has gained 14.4% so far this year, while in the year 2024, WPC gained